CORDIS
EU research results

CORDIS

English EN
From sea-bed to test-bed:<br/>harvesting the potential of marine microbes for industrial biotechnology

From sea-bed to test-bed:
harvesting the potential of marine microbes for industrial biotechnology

Objective

SeaBioTech is a 48-month project designed and driven by SMEs to create innovative marine biodiscovery pipelines as a means to convert the potential of marine biotechnology into novel industrial products for the pharmaceutical (human and aquaculture), cosmetic, functional food and industrial chemistry sectors. SeaBioTech will reduce barriers to successful industrial exploitation of marine biodiversity for companies more accustomed to ‘terrestrial’ biotechnology. SeaBioTech directly addresses five key challenges to remove bottlenecks in the marine biodiscovery pipeline, leading to (1) improvements in the quality of marine resources available for biotechnological exploitation, (2) improvement in technical aspects of the biodiscovery pipeline to shorten time to market, and (3) developing sustainable modes of supply of raw materials for industry. The two last challenges centre on enabling activities to enhance the marine biodiscovery process: first, clarification of legal aspects to facilitate access to marine resources, their sustainable use, and their secure exploitation; second, to create an improved framework for access to marine biotechnology data and research materials. To achieve its goals, SeaBioTech brings together complementary and world-leading experts, integrating biology, genomics, natural product chemistry, bioactivity testing, industrial bioprocessing, legal aspects, market analysis and knowledge exchange. The expertise assembled within the consortium reflects the industry-defined needs, from the SME partners’ initial definition of market and product opportunities to their ultimate proof-of-concept demonstration activities. SeaBioTech will have significant impact on research and technology, on innovation, on European competitiveness and on economic growth. It will provide a model to accelerate the development of European biotechnology into a world leading position.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

UNIVERSITY OF STRATHCLYDE

Address

Richmond Street 16
G1 1xq Glasgow

United Kingdom

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 1 803 588

Administrative Contact

Martin Gregory (Mr.)

Participants (15)

Sort alphabetically

Sort by EU Contribution

Expand all

TEKNOLOGIAN TUTKIMUSKESKUS VTT

Finland

NOVAMEN SAS

France

INGENZA LIMITED

United Kingdom

EU Contribution

€ 406 476

PROKAZYME EHF

Iceland

EU Contribution

€ 91 680

MARINE BIOPOLYMERS LIMITED

United Kingdom

EU Contribution

€ 229 811

PHARMAQ AS*

Norway

EU Contribution

€ 601 578

AXXAM SPA

Italy

EU Contribution

€ 556 420

Horizon Discovery Limited

United Kingdom

EU Contribution

€ 675 240

MATIS OHF

Iceland

EU Contribution

€ 709 450

LUNDS UNIVERSITET

Sweden

EU Contribution

€ 370 744

JULIUS-MAXIMILIANS-UNIVERSITAT WURZBURG

Germany

EU Contribution

€ 508 209

HELLENIC CENTRE FOR MARINE RESEARCH

Greece

EU Contribution

€ 387 503

THE SCOTTISH ASSOCIATION FOR MARINESCIENCE LBG

United Kingdom

EU Contribution

€ 581 486

ACIES Consulting Group SAS

France

EU Contribution

€ 122 727

Teknologian tutkimuskeskus VTT Oy

Finland

EU Contribution

€ 416 804

Project information

Grant agreement ID: 311932

Status

Closed project

  • Start date

    1 August 2012

  • End date

    31 July 2016

Funded under:

FP7-KBBE

  • Overall budget:

    € 9 928 143,48

  • EU contribution

    € 7 461 716

Coordinated by:

UNIVERSITY OF STRATHCLYDE

United Kingdom

This project is featured in...